3v9t: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "3v9t" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3v9t.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_3v9t", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_3v9t| PDB=3v9t | SCENE= }} | |||
===Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_22225641}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 22225641 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_22225641}} | |||
==About this Structure== | |||
[[3v9t]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3V9T OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:022225641</ref><references group="xtra"/> | |||
[[Category: Homo sapiens]] | |||
[[Category: Hanzawa, H.]] | |||
[[Category: Matsui, Y.]] | |||
[[Category: Three-layered alpha-helical sandwich]] | |||
[[Category: Transcription regulation]] | |||
[[Category: Transcription-transcription regulator complex]] | |||
Revision as of 07:20, 1 February 2012
Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator
Template:ABSTRACT PUBMED 22225641
About this Structure
3v9t is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Furukawa A, Arita T, Fukuzaki T, Satoh S, Mori M, Honda T, Matsui Y, Wakabayashi K, Hayashi S, Araki K, Ohsumi J. Substituents at the naphthalene C3 position of (-)-Cercosporamide derivatives significantly affect the maximal efficacy as PPARgamma partial agonists. Bioorg Med Chem Lett. 2012 Feb 1;22(3):1348-51. Epub 2011 Dec 16. PMID:22225641 doi:10.1016/j.bmcl.2011.12.066
